@article{oai:nagasaki-u.repo.nii.ac.jp:00000800,
 author = {Yoshikawa, Naoki and Fumoto, Shintaro and Yoshikawa, Keiko and Hu, Die and Okami, Kazuya and Kato, Riku and Nakashima, Mikiro and Miyamoto, Hirotaka and Nishida, Koyo},
 issue = {4},
 journal = {Pharmaceutics},
 month = {Apr},
 note = {Understanding the in vivo fate of lipoplex, which is composed of cationic liposomes and DNA, is an important issue toward gene therapy. In disease conditions, the fate of lipoplex might change compared with the normal condition. Here, we examined the contribution of interaction with serum components to in vivo transfection using lipoplex in hepatitis mice. Prior to administration, lipoplex was incubated with serum or albumin. In the liver, the interaction with albumin enhanced gene expression in hepatitis mice, while in the lung, the interaction with serum or albumin enhanced it. In normal mice, the interaction with albumin did not enhance hepatic and pulmonary gene expression. Furthermore, hepatic and pulmonary gene expression levels of albumin-interacted lipoplex were correlated with serum transaminases in hepatitis mice. The albumin interaction increased the hepatic accumulation of lipoplex and serum tumor necrosis factor-α level. We suggest that the interaction with albumin enhanced the inflammation level after the administration of lipoplex in hepatitis mice. Consequently, the enhancement of the inflammation level might enhance the gene expression level. Information obtained in the current study will be valuable toward future clinical application of the lipoplex., Pharmaceutics, 12(4), art.no.341; 2020},
 title = {Interaction of Lipoplex with Albumin Enhances Gene Expression in Hepatitis Mice},
 volume = {12},
 year = {2020}
}